Enveda, a Colorado-based biotech, has received a $20 million investment from French pharma major Sanofi. According to Enveda, ...

Paris: Sanofi has announced that the Ministry of Health, Labour and Welfare (MHLW) in Japan has approved Sarclisa, in ...

Sanofi invests in Enveda, reaffirming the industry’s confidence in its AI drug discovery platform and ability to deliver differentiated medicines.

Enveda gets support from Sanofi to advance AI-driven drug discovery to clinical trials: Boulder, Colorado Friday, February 28, 2025, 16:00 Hrs [IST] Enveda, a leading biotechnolog ...

Sanofi India announced that its Board of Directors has approved of the company selling its commercial premises, being five floors and corresponding car-parking spaces in the building known as ...

Transitioned lead commercial responsibility of Nuvaxovid COVID-19 vaccine to Sanofi beginning with the 2025-2026 season Achieved total revenue of $88 million in ...

Bar-Joseph brings extensive expertise from Sanofi, a leading global pharmaceutical company. As the VP and Head of R&D Data and Computational Sciences, he led multidisciplinary teams in machine ...

Sanofi said this morning that its pipeline ... Escherichia coli (EPEC), and respiratory syncytial virus (RSV). “Building on our successful recent launches, we are making decisive choices to ...

The building in Woodcliff Lake rose in value despite the trend away from suburban office space with work-from-home and a ...

The partnership between Sanofi and CytoReason – for an undisclosed ... to find new biomarkers and therapeutic targets, as well as building models of the cancers and methods to predict if ...

Marya Lieberman is a chemistry professor whose NIH-funded project is focused on developing a tool to detect poor-quality ...